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MODIFIED 
ULTRAFILTRATION 
IMPROVES CEREBRAL 
METABOLIC RECOVERY 
AFTER CIRCULATORY 
ARREST 
Modified ultrafiltration uses hemofiltration of the patient and bypass circuit after 
separation from cardiopulmonary b pass to reverse hemodilution and edema. This 
study investigated the effect of modified ultrafiltration on cerebral metabolic 
recovery after deep hypothermic circulatory arrest. Twenty-six 1-week-old piglets (2 
to 3 kg) were supported by cardiopulmonary b pass (37 ° C) at 100 ml. kg-1. min- i  
and cooled to 18 ° C. Animals underwent 90 minutes of circulatory arrest followed by 
rewarming to 37 ° C. After being weaned from cardiopulmonary b pass, animals were 
divided into three groups: controls (n = 10); modified ultrafiltration for 20 minutes 
(n = 9); transfusion of hemoconcentrated blood for 20 minutes (n = 7). Global 
cerebral blood flow was measured by xenon 133 clearance methods: stage I--before 
cardiopulmonary b pass; stage I Im5 minutes after cardiopulmonary b pass; and 
stage I I I - -25 minutes after cardiopulmonary bypass. Cerebral metabolic rate of 
oxygen consumption, cerebral oxygen delivery, and hematocrit value were calculated 
for each time point. At point III, the hematocrit value (percent) was elevated above 
baseline in the ultrafiltration and transfusion groups (44 -+ 1.8, 42 - 1.8 versus 28 - 
1.7, 30 -+ 0.7, respectively, p < 0.05). Cerebral oxygen delivery (ml. 100 gm -~. 
min - i)  increased significantly above baseline at point I I I  after ultrafiltration (4.98 
_ 0.32 versus 3.85 - 0.16,p < 0.05) or transfusion (4.59 + 0.17 versus 3.89 -+ 0.06, 
p < 0.05) and decreased below baseline in the control group (2.77 - 0.19 versus 3.81 
_ 0.16,p < 0.05). Ninety minutes of deep hypothermic circulatory arrest resuited in 
impaired cerebral metabolic oxygen consumption (ml. 100 gm - i .  min - i)  at point 
I I I  in the control group (1.95 - 0.15 versus 2.47 _ 0.07, p < 0.05) and transfusion 
group (1.72 + 0.10 versus 2.39 --. 0.15, p < 0.05). After modified ultrafiltration, 
however, cerebral metabolic oxygen consumption at point I I I  had increased signif- 
icantly from baseline (3.12 _+ 0.24 versus 2.48 - 0.13,p < 0.05), indicating that the 
decrease in cerebral metabolism immediately after deep hypothermic circulatory 
arrest is reversible and may not represent permanent cerebral injury. Use of 
modified ultrafiltration after cardiopulmonary bypass may reduce brain injury 
associated with deep hypothermic eirculatory arrest. (J THORAC CARDIOVASC SURG 
1995;109:744-52) 
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D eep hypothermic irculatory arrest (DHCA) is 
oßen used during the repair of complex congen- 
ital heart defects in neonates and infants. Transient 
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and permanent neurologic sequelae may be ob- 
served after DHCA. 1-3 Recent investigations have 
demonstrated that DHCA results in a decreased 
cerebral metabolic rate of oxygen consumption 
(CMRO2) after separation from cardiopulmonary 
bypass (CPB). 4' 5 The decrease in CMRO 2 may be 
related to duration of DHCA as well as other factors 
and has been used as a marker of cerebral injury. 4-8 
After separation from CPB after DHCA, cerebral 
hypoperfusion and elevated cerebral vascular esis- 
tance impair cerebral oxygen delivery? -lz Cerebral 
oxygen delivery may also be compromised by a 
decrease in cardiac output, reduction in hemoglo- 
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bin, elevated pulmonary vascular esistance, hypox- 
emia, and organ edema increasing the risk of neu- 
rologic injury during this vulnerable period after 
CPB. 
Modified ultrafiltration (MUF) is a technique that 
uses ultrafiltration of the patient and hemofiltration 
of the CPB circuit after separation from bypass to 
reverse hemodilution occurring during cardiac op- 
erations.13, 14 In children undergoing CPB for repair 
of congenital heart defects, MUF has been demon- 
strated to reduce total body water and decrease 
pulmonary vascular esistance, as well as to increase 
mean arterial pressure and cardiac index. 15' 16 How- 
ever, the effects of MUF on cerebral function after 
DHCA have not been examined. MUF may improve 
cerebral metabolism in the vulnerable period after 
DHCA by raising post-CPB hemoglobin values to 
increase cerebral oxygen delivery. This study inves- 
tigates the effect of  MUF on cerebral metabolic 
recovery after DHCA in a 1-week-old piglet model. 
Methods 
Twenty-eight 1-week-old piglets weighing 2 to 3 kg were 
studied with approval of the institution's animal care and 
use committee and in compliance with the "Guide for the 
Care and Use of Laboratory Animals" prepared by the 
Institute of Laboratory Animal Resources and published 
by the National Institutes of Health (NIH publication No. 
85-23, revised 1985). Animals were premedicated with 
intramuscular ketamine (20 mg/kg), intubated, and me- 
chanically ventilated (Infant Ventilator; Sechrist Indus- 
tries, Anaheim, Calif.). Methylprednisolone (40 mg/kg) 
was given intravenously. After a bolus of intravenous 
fentanyl (100/~g) and pancuronium (0.1 mg/kg), anesthe- 
sia was maintained with continuous fentanyl infusion (50 
/~g. kg 1. hr-1). A femoral artery catheter was placed for 
measurement of mean arterial pressure and arterial blood 
sampling. A median sternotomy was performed and an 8 
mm ultrasonic flow probe (Transonic Systems, Ithaca, 
N.Y.) was positioned around the main pulmonary artery 
for measurement of cardiac output. A left atrial catheter 
was inserted and a temperature probe was placed in the 
nasopharynx. A burr hole was made in the skuU at the crus 
of the sagittal and coronal sutures to allow sagittal sinus 
blood sampling. 
Hemispheric erebral blood flow (CBF) was measured 
by the xenon (133Xe) clearance technique. 17 Two extracra- 
nial 16 mm cadmium telluride gamma emission detectors 
were placed over the right and left temporal lobes. 
Radioactive xenon (1.5 mCi in 2 ml of normal saline 
solution) was injected into the left atrial catheter and 
radioactive decay recorded from each hemisphere over a 
5-minute period. Hemispheric CBF was determined by a 
modification of the initial slope index method, is By this 
method, CBF = (slope)(3')(100), where slope is the 
natural ogarithm of the 133Xe clearance 1 minute after 
the peak of the curve, 3' is the tissue-blood partition 
coefficient for xenon, corrected for hematocrit and tern- 
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Fig. 1. Modified placement of the hemofilter after sepa- 
ration from CPB and during ultrafiltration. UF, Ultrafil- 
ter. 
perature, 19 and 100 converts ml-gm 1. min-a to ml. 100 
gin- 1. min- 1. Global CBF was determined as the average of 
the individually calculated hemispheric blood flows. Baseline 
~33Xe was measured before each determination and sub- 
tracted to correct curves for residual xenon. 
A schematic diagram of the experimental protocol is 
shown in Fig. 1. After instrumentation, data were col- 
lected before CPB at 37 ° C (stage I). Animals were then 
supported by CPB at 100 ml. kg -1- min -1 at 37 ° C and 
cooled by perfusion to 17.7 ° +- 0.1°C over a 23-minute 
period. All animals underwent 90 minutes of DHCA 
followed by a rewarming period with a mean duration of 
27 -- 1 minutes to 36.0 ° + 0.2 ° C. Animals were weaned 
from CPB and data were collected 5 minutes after sepa- 
ration from CPB (stage II). Animals were divided into 
three groups: control (n = 10)--observation for 20 min- 
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Fig. 2. Experimental protocol and data collection sequence: After instrumentation, baseline measure- 
ments (I) were obtained. Animals were supported by CPB at 100 ml- kg -a • min -a and 37 ° C, and then 
cooled to 18 ° C over 23 minutes. Animals underwent 90 minutes of DHCA, followed by rewarming to 36 ° C 
over a 27-minute period. Data were obtained 5 minutes after separation from CPB (II). The experimental 
groups were as follows: A, CTL, Observation for 20 minutes without intervention (n = 10); B, MUF, 
modified ultrafiltration for 16 minutes (n = 9); C, Tx, transfusion of hemoconcentrated blood over 20 
minutes (n = 7). Final measurements were then obtained 25 minutes after separation from CPB (III). 
utes without intervention; MUF (n = 9)--MUF for 16 _+ 
1 minutes; transfusion (n = 7)--transfusion of non- 
leukocyte-depleted hemoconcentrated blood over 20 min- 
utes to achieve ahematocrit value greater than 40%. Data 
were eollected 25 minutes after separation from CPB 
(stage III) (Fig. 2). 
Nasopharyngeal temperature, mean arterial pressure, 
heart rate, cardiac output, left atrial pressure, arterial and 
sagittal sinus blood gases, hemoglobin eoncentration, and 
CBF were measured at each stage. Brains were not 
weighed at the completion of the experiment. The cere- 
bral arteriovenous oxygen content difference (cCaO 2 - vO2) 
was calculated as  CaO 2 - CssO2,  where CssQ is the sagittal 
sinus oxygen content. A GEM-STAT blood gas/electrolyte 
monitor (Mallinckrodt, Ann Arbor, Mich.) was used to 
measure blood gases. Oxygen saturation and hemoglobin 
concentration were measured by an IIA82 CO-Oximeter 
System (Instmmentation Laboratory, Lexington, Mass.). 
The CMRO» cerebral oxygen delivery (cD. O2), and cere- 
bral oxygen extraction ratio (cO2ER) were calculated at each 
stage as follows: 
CMRO 2 (ml. 100 gm brain -1. min -1)  = (cCaO 2 - vO2)(CBF ) 
cD. O2(ml 02" 100 gm brain -1. min 1) = (CaO2)(CBF) 
cO2ER(%) = CMRO2/cD • 02 
Data were analyzed with the Student's paired t test to 
compare results within each group. The unpaired t test 
and analysis of variance were used to compared results 
between groups. All results are expressed as means -+ 
standard errors. Significance was defined as p < 0.05. 
Results 
The study was successfully completed in 26 of the 
28 animals. Two animals were excluded, one for a 
markedly abnormal baseline CMRO2 value (con- 
trol) and one for hypotension during MUF,  which 
precluded the ability to complete the study protocol. 
No significant differences existed between the 
groups of  animals in mean arterial pressure, heart 
rate, cardiac output, hematocrit, CMRO2, cerebral 
oxygen delivery, and cerebral oxygen extraction ra- 
tio before CPB (Tables I and II). The baseline 
nasopharyngeal temperature for the transfusion 
group was significantly lower than for the other 
groups, but this was not believed to be of physiologic 
importance. CBF was slightly but significantly lower 
in the transfusion group than in the MUF and 
control groups before CPB (p < 0.05). No signifi- 
cant differences in hemodynamic parameters were 
detectable between animal groups during CPB. 
Five minutes after the animals were weaned ffom 
CPB, there were no significant differences between 
groups in mean arterial pressure, cardiac output, 
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Table I. Summary data for all animals 
I I I  111 
NPT (°C) 
CTL 36.9 -- 0.3 35.7 -+ 0.3~: 35.0 --- 0.3~:§ 
MUF 36.3 _+ 0.3 35.7 +_ 0.2 34.0 _+ 0.3":~§ 
Tx 35.9 ± 0.2* 35.9 ± 0.2 34.9 ± 0.27:~§ 
MAP (mm Hg) 
CTL 51.6 _+ 2.6 41.3 _+ 3.4:~ 38.6 --_ 2.85 
MUF 57.2 ± 2.9 45.4 ± 2.5 55.2 ± 1.5" 
Tx 60.7 ± 4.2 48.4 ± 3.4:~ 65.9 ± 6.1"§ 
HR (beats/min) 
CTL 185 _+ 12 163 +_ 3 171 _+ 6 
MUF 187 ± 11 170 ± 5 152 _+ 4":~§ 
Tx 162 + 9 167 + 8 156 ± 8 
CO (tal/min) 
C1% 381 -+ 13 395 ± 14 356 ± 22§ 
MUF 327 ± 45 372 --- 44¢ 366 ± 42:~ 
Tx 411 _+ 22 426 --- 16 426 -+ 45 
LAP (mm Hg) 
CTL - -  5 ± 0.6 4 ± 0.5 
MUF - -  6 ± 0.6 7 ± 0.8*§ 
Tx - -  3 -+ 0.3t 7 + 0.8*§ 
Study stages:/, Before CPB; I/, 5 minutes after CPB; III, 25 minutes after 
CPB. Mean values +- standard error. NPT, Nasopharyngeat temperature; 
MAP, mean arterial pressure; HR, heart rate; CO, cardiac output; LAP, left 
atrial pressure; CTL, control; MUF, ultrafiltered; Tx, transfused. 
*p < 0.05; MUF and Tx versus CTL. 
?p < 0.05 MUF versus Tx. 
~p < 0.05 stages II and III versus I. 
§p < 0.05 stage III versus II. 
hematocrit, CBF, CMRO2, or cerebral oxygen de- 
livery. The left atrial pressure was significantly lower 
in the transfusion group than in the other groups 
(p < 0.05). There were no significant differences 
from pre-CPB baseline values in hematocrit, 
CMRO2, or cerebral oxygen delivery in any group. 
The cerebral oxygen extraction ratio increased sig- 
nificantly above pre-CPB value in control animals 
(p < 0.05), whereas values in the MUF and trans- 
fusion groups were not different from baseline. CBF 
had decreased significantly from baseline values in 
the control and MUF animals (p < 0.05). 
In the control animals after 20 minutes of obser- 
vation after separation ffom CPB (stage III), there 
was a significant decrease in CBF, CMRO2, and 
cerebral oxygen delivery (p < 0.05) compared with 
stage II values (Figs. 3 and 4). Hematocrit, left atrial 
pressure, and cerebral oxygen extraction ratio, how- 
ever, did not change significantly from stage II 
values. 
After MUF (stage III), there was a significant 
increase (p < 0.05) in hematocrit, CMRO2, and 
cerebral oxygen delivery compared with stage I and 
II values (Figs. 3 and 4). The cerebral oxygen 
Table II. Summary data for all animals 
I I I I I I 
HCT 
CTL 27 -+ 1 
MUF 28 ± 2 
Tx 30-+1 
CBF 
CTL 32.1 ± 0.8 
MUF 31.8 ± 1.3 
Tx 29.1 _+ 0.8* 
cD • 02 
CTL 3.81 ± 0.16 
MUF 3.85 _+ 0.16 
Tx 3.89 + 0.06 
CMRO2 
CTL 2.47 ± 0.07 
MUF 2.48 -4- 0.13 
Tx 2.39 ± 0.15 
cO2ER 
CTL 59.6 ± 2.4 
MUF 58.6 ± 3.2 
Tx 55.7 _+ 0.5 
28 +- 1 28 --- 2 
27 --- 1 44 --- 2":~§ 
28-1  42±2'¢§  
28.4 -+ 1.5:~ 22.4 -+ 1.4~:§ 
27.8 --- 1.0~: 25.5 ± 1.4~ 
28.6 ± 0.8 25.1 ± 1.6 
3.50 + 0.24 2.77 -+- 0.19~:§ 
3.34 -+ 0.13 4.98 -+ 0.32"~§ 
3.47 -+ 0.35 4.59 ± 0.17"~§ 
2.65 --- 0.25 1.95 -+ 0.15¢§ 
2.38 ± 0.08 3.12 ± 0.24":~§ 
1.97 ± 0.29 1.72 + 0.10te 
67.8 + 3.2~ 64.9 -+ 3.2 
65.0 -+ 2.7 57.5 ± 2.0§ 
51.3 ± 3.7"~ 35.1 ± 2.5"t¢§ 
Study stages:/, Before CPB; 1/, 5 minutes after CPB; III, 25 minutes after 
CPB. Mean values _+ standard error. HCT, Hematocrit (%); CBF,, cerebrai 
blood flow (ml. 100 gm -1- min-l); cD" O» cerebral oxygen delivery (ml. 100 
gm -1 • min-l); CMRO» cerebral metabofic rate of oxygen (tal • 100 gm x. 
min); cOBR (%), cerebral oxygen extraction ratio. CTL, Control; MUF, 
ultrafiltered; Tx, transfused. 
• p < 0.05; MUF and Tx versus CTL. 
1"p < 0.05 MUF versus Tx. 
Sp < 0.05 stages n and III versus I. 
Bp < 0.05 stage III versus II. 
extraction ratio had decreased significantly ffom 
stage II (p < 0.05). At stage III, CMRO2 was 
significantly higher in the MUF group than in the 
control and transfusion animals (3.12 __ 0.24 versus 
1.95 __ 0.15 and 1.72 __ 0.10 ml" 100 gm -1. min -1, 
p < 0.05), and cerebral oxygen delivery was signifi- 
cantly higher than in control animals (4.98 __ 0.32 
versus 2.77 ___ 0.19 ml" 100 gm -1" min- l ,p < 0.05). 
However, there was no significant difference in 
cerebral oxygen delivery between the MUF and 
transfusion groups (4.98 _ 0.32 versus 4.59 _+ 0.17 
ml. 100 gm -1. min -1) at this time. 
After transfusion, there was a significant increase 
in hematocrit and cerebral oxygen delivery from 
stage II (p < 0.05). Despite this increase, CMRO2 
decreased significantly compared with measure- 
ments in stages I and II (1.72 __ 0.10 versus 2.39 ___ 
0.15 and 1.97 __ 0.29 ml" 100 gm -1. min -1, p < 
0.05). The cerebral oxygen extraction ratio in the 
transfused animals also decreased significantly from 
stages I and II (35.1% __ 2.5% versus 55.7% -- 0.5% 
and 51.3% __ 3.7%,p < 0.05) and as compared with 
measurements in the control and MUF groups 
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Fig. 3. Cerebral oxygen delivery (cD. OB measurements before and after DHCA. There was a significant 
decrease incD. 02 in CTL animals compared with MUF and Tx groups at stage III. Mean data --- standard 
error; *p ± 0.0001, CTL versus MUF and Tx. CTL, Control; MUF, ultrafiltration; Tx; transfusion./, Before 
CPB; IL 5 minutes after CPB; III, 25 minutes after CPB. 
(35.1% ___ 2.5% versus 64.9% + 3.2% and 57.5% --- 
2.0%, p < 0.05). There was no significant difference 
in cerebral oxygen delivery compared with the MUF 
group at stage III. CMRO2 did not differ signifi- 
cantly from that in control animals at stage III (1.72 _ 
0.10 versus 1.95 --- 0.15 ml. 100 gm -1" min-l). 
There was a difference between hemodynamic 
parameters between the MUF and transfusion ani- 
mals versus the control group. Control animals had 
a significant decline in cardiac output and mean 
arterial pressure during the 20-minute period of 
observation (p < 0.05), indicating a deterioration i  
hemodynamic stability. MUF and transfusion ani- 
mals were able to maintain cardiac output and mean 
arterial pressure at pre-CPB values. These differ- 
ences may be accounted for by the increased left 
atrial pressure after transfusion and MUF, which 
was not seen in the control group. 
Discussion 
Transient and permanent europsychologic injury 
may occur in up to 25% of infants undergoing CPB 
with DHCA. 2 Most clinical and experimental inves- 
tigations have focused primarily on the effects of 
cerebral protection strategies used during the cool- 
ing and arrest phases of operations for congenital 
heart disease. 6' 7,11-12, 0-26 Cerebral injury may also 
occur after arrest in the rewarming period by reper- 
fusion injury and in the period after separation from 
CPB. The period after separation from CPB is 
characterized by cerebral hypoperfusion and ele- 
vated cerebral vascular resistance. 9-12 A reduction i  
CMRO2 has also been demonstrated during this 
time. 4-6 An increase in metabolic demand may be 
needed at this time to repay an oxygen debt incurred 
during arrest, and further neurologic injury may 
occur if the brain cannot increase CMRO2 after 
DHCA. Increasing cerebral oxygen delivery in the 
period after separation from CPB in an attempt to 
drive metabolism is one method that might prevent 
or lessen cerebral injury after DHCA. 
This study demonstrates that in this model of 
neonatal CPB simply increasing cerebral oxygen 
delivery by raising the hematocrit value does not 
result in increased CMRO» and cerebral metabo- 
lism remains impaired after DHCA. In fact, control 
and transfused animals had a similar impairment in
cerebral metabolism 25 minutes after separation 
from CPB after DHCA (Fig. 4). Even though addi- 
tional oxygen is available for consumption after 
transfusion, the brain is unable to increase its use of 
oxygen; therefore, cerebral oxygen extraction de- 
creases. MUF resulted in an increase in cerebral 
oxygen delivery and CMRO2 above baseline, indi- 
cating that oxygen use by the brain is improved. 
These findings suggest hat MUF acts by mecha- 
nisms other than an increase in cerebral oxygen 
delivery to improve oxygen use by the brain after 
DHCA. 
The level of CMRO 2 after DHCA necessary for 
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Fig. 4. CMRO2 measurements before and after DHCA. There was a significant increase in CMRO2 in 
MUF animals compared with CTL and Tx groups at stage III. Mean data - standard error; *p < 0.001, 
MUF versus CTL and Tx. CTL, Control; MUF, ultrafiltration; Tx, transfusion./, Before CPB; I/, 5 minutes 
after CPB; III, 25 minutes after CPB. 
maximal recovery of neurologic function is un- 
known. A high level of oxygen use may be needed to 
restore cellular stores depleted uring the period of 
ischemia. Return of CMRO2 to pre-CPB values may 
be inadequate and could result in continuing cellular 
injury. After DHCA, control and transfused animals 
have a similar impairment incerebral metabolism 25 
minutes after separation from CPB, suggesting that 
CMRO2 is independent of cerebral oxygen delivery 
(Fig. 5). When cerebral oxygen delivery is increased 
by transfusion, CMRO2 does not increase and cere- 
bral oxygen extraction falls, suggesting that the brain 
cannot use the additional oxygen. This finding em- 
phasizes that the injury seen in this model after 
DHCA is one of limited oxygen use by the brain. 
This level of oxygen use after DHCA may be less 
than is needed for optimal cellular recovery. The 
ability of MUF to increase both cerebral oxygen 
delivery and CMRO2 after DHCA suggests hat the 
supply and demand relationship has changed. It 
appears that the MUF animals are on a different 
oxygen supply and demand curve than the control 
and transfused animals. The MUF animals are able 
to use the additional oxygen delivered to the brain. 
This is demonstrated not only by an increase in 
CMRO2 but also by the fact that cerebral oxygen 
extraction does not decrease in the face of an 
elevation in cerebral oxygen delivery. This high level 
of oxygen use may be necessary torepay the oxygen 
debt incurred during arrest. It is not known from 
this study whether CMRO2 after MUF is maximal 
or if it could be increased even more by other 
interventions. Long-term neurologic outcome stud- 
ies will be needed to determine the ideal level of 
CMRO 2 after DHCA necessary for maximal recov- 
ery of neurologic function. 
Possible mechanisms for the improvement in ox- 
ygen use by the brain after MUF include decreased 
cerebral edema, removal of toxic substances, and 
alteration of leukocyte-mediated injury. Total body 
water is increased after CPB and may result in tissue 
edema nd organ dysfunction. The increase in total 
body water is greatest in patients with low weights 
and younger ages who undergo long periods of 
hypothermic low-flow CPB. 27 MUF has been shown 
to decrease postoperative total body water in these 
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Fig. 5. Hypothetical cerebral oxygen supply and demand 
curves at 25 minutes after separation from CPB after 
DHCA. In this model CMRO 2 does not change signifi- 
cantly with varying levels of cerebral oxygen delivery 
(cD. 02), suggesting that control and transfusion animals 
are on the supply-independent (fla ) portion of the curve. 
The ability of MUF to increase both cD. 02 and CMRO2 
implies that these animals are on a different curve than 
control and transfusion animals. From the current study it 
cannot be determined if the MUF animals are on the 
supply-dependent (straight dotted line) or supply-indepen- 
dent (curved otted line) portion of the curve. 
patients. 15The reduction in total body water after 
MUF may decrease cerebral edema, thereby im- 
proving diffusion and use of oxygen by the brain. 
Analysis of the filtrate after standard hemofiltra- 
tion in adult patients during CPB revealed toxic 
peptides uch as myocardial depressant factor and 
other vasoactive factors. 2s Serum levels of tumor 
necrosis factor, a cytokine responsible for leukocyte 
adhesion and increased vascular permeability, were 
significantly reduced after operations in children 
who underwent hemofiltration during CPB, and 
high levels of tumor necrosis factor were detected in
the filtrate. 29 MUF has also been shown to reduce 
serum levels of interleukin-8, a neutrophil chemo- 
tactic factor, in children undergoing CPB. 3° Further 
studies will need to be performed for the means by 
which MUF improves oxygen use by the brain to be 
fully understood. 
There are several imitations to this study. The 
cerebral metabolic response patterns demonstrated 
in these animals are acute changes only. However, 
recent investigations have demonstrated that 
DHCA is associated with an impairment in long- 
term neurologic outcome that may be related to the 
pattern of cerebral metabolic recovery seen in the 
immediate post-CPB period. 3~ The measurements 
of CBF are global and do not provide information 
about regional blood flow. However, this method of 
CBF measurement was chosen to parallel methods 
used in patients at this institution, therefore making 
results produced in the laboratory setting clinically 
applicable. The brains were not examined histolog- 
ically or on a molecular level. Further studies will 
need to be performed to help understand these 
acute changes in cerebral metabolism on a molecu- 
lar level. 
In summary, this study demonstrates that 90 
minutes of DHCA results in impaired CMRO2 25 
minutes after separation from CPB, consistent 
with previous experimental nd clinical studies. »'6 
Initially the mechanism for decreased CMROz 
after DHCA appeared to be a decrease in cerebral 
oxygen delivery. However, simply increasing cere- 
bral oxygen delivery by raising the hematocrit 
value did not improve CMRO2 and cerebral me- 
tabolism remained impaired. After MUF, cerebral 
oxygen delivery and CMRO2 both increase and 
indicate that the brain can recover from metabolic 
dysfunction after DHCA. This ability to acutely 
improve cerebral metabolism after DHCA has not 
been previously demonstrated. High levels of 
CMRO2 after DHCA may be necessary to repay 
the debt incurred uring arrest. Thus the return of 
CMROz to pre-CPB levels may not signify an 
absence of cerebral injury. It may be possible to 
reduce brain injury associated with DHCA by 
using MUF to improve cerebral oxygen use after 
the patient has been weaned flora CPB. This 
improvement in cerebral oxygen delivery and use 
after separation from CPB may also prevent fur- 
ther neuropsychologic injury caused by low car- 
diac output, hypotension, or hypoxemia in the 
post-CPB period. 
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Discuss ion  
Dr. Richard A. Jonas (Boston, Mass.). This is a most 
interesting result. Obviously all of us wonder about the 
mechanisms. You stated that you thought he result might 
be related to a reduction in cerebral edema. Did you in 
fact measure the water content of the brains? 
Dr. Skaryak. We did not. 
Dr. Jonas. CMRO 2 is exquisitely sensitive to tempera- 
7 5 2 Skaryak et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
April 1995 
ture. With the technique of MUF that you have described, 
I understand that blood is passing from the reservoir 
through the heat exchanger. Therefore, you are pumping 
warm oxygenated blood into the patient with the MUF 
circuit. Did you measure directly cerebral temperature to
exclude the possibility that this result simply represents a 
temperature-related effect on CMRO2? 
Dr. Skaryak. We placed a temperature probe in the 
subcortical region of the brain. There were no differences 
between groups in subcortical brain temperatures 25 
minutes after separation from CPB. 
Dr. Julie A. Swain (Las Vegas, Nev.). Did you measure 
cerebral perfusion pressure or intercranial pressure? 
Dr. Skaryak. We did not measure cerebral perfusion 
pressure or intracerebral pressure. 
Dr. Randall B. Griepp (New York, N.Y.). The implica- 
tions of this work are exciting. I would like to comment, 
however, on a consistent discrepancy between your work 
and ours with regard to CMRO 2 in the early postoperative 
period. In our puppy model, in which blood flow is 
measured by microspheres, we do not demonstrate a 
reduction in CMROa even in animals subjected to a 
period of arrest hat results in clinical and electroencepha- 
lographie vidence of cerebral injury. In your pig model 
with CBF being measured by radioactive xenon clearance, 
you consistently demonstrate a reduction of CMRO2 in 
early postoperative period. I think it is possible that the 
results that you have presented may provide a possible 
explanation for this discrepancy. Our experimental model 
is a survival one, and to get a puppy through a period of 
CPB and circulatory arrest, it is necessary to keep the 
animal extremely dry; accordingly, we are parsimonious 
with regard to fluid administration throughout the exper- 
imental period. In your model in which you do not need to 
be concerned about weaning from respiratory support, it 
may be possible that at the end of the experimental period 
the animals have some degree of cerebral edema. With 
reduction of cerebral edema by MUF, CMR02 returns to 
normal. Thus I am asking you to comment on the possi- 
bility that the explanation for your results is not necessar- 
ily a lower titer of inflammatory mediators, but rather a 
reduction in cerebral edema. 
Dr. Skaryak. A decrease in cerebral edema is one 
possible mechanism of how MUF works. Martin Elliott 
and colleagues have shown that MUF reduces total body 
water accumulation, especially in younger, lower weight 
patients undergoing hypothermic low-flow bypass. 
Other studies have demonstrated that tumor necrosis 
factor and interleukin-8 levels were decreased in pa- 
tients after MUF. Coraim and colleagues analyzed the 
ultrafiltrate and found a peak in high molecular weight 
peptides, very similar to myocardial depressant faetor, sug- 
gesting that elimination of toxic peptides could be a possible 
mechanism. 
